Triple-negative breast cancer (TNBC), which lacks the expression of estrogen receptor and progesterone receptor as well as human epidermal growth factor receptor 2 (HER2) amplification, contributes to 15–20% of breast cancer [1]. Here, ERBB2 is linked to breast carcinoma.